These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 38623137)
1. Comparison of Efficacy of Topical Betamethasone Dipropionate and Topical Minoxidil in Patients With Alopecia Areata. Aslam S; Awan AZ; Iqbal MM; Saeed S; Saeed M; Liaqat Z; Dar SA; Ali S; Asif MA; Mehmood Qadri H Cureus; 2024 Mar; 16(3):e56282. PubMed ID: 38623137 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of topical latanoprost versus minoxidil and betamethasone valerate on the treatment of alopecia areata. El-Ashmawy AA; El-Maadawy IH; El-Maghraby GM J Dermatolog Treat; 2018 Feb; 29(1):55-64. PubMed ID: 28521549 [TBL] [Abstract][Full Text] [Related]
3. Comparison of efficacy, safety and satisfaction of latanoprost versus minoxidil, betamethasone and in combination in patients with alopecia areata: A blinded multiple group randomized controlled trial. Ghassemi M; Yazdanian N; Behrangi E; Jafari M; Goodarzi A Dermatol Ther; 2022 Dec; 35(12):e15943. PubMed ID: 36257912 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Efficacy of Autologous Platelet Rich Plasma Therapy With 5% Topical Minoxidil Spray in Treating Alopecia Areata: A Head-to-Head Assessment of Novel Approaches. Muhammad A; Saleem S; Khan S; Virdi G; Arshad S; Muhammad S; Younas MT; Saeed A; Khan DS; Ikram A Cureus; 2024 Jun; 16(6):e61878. PubMed ID: 38975521 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trial. Mancuso G; Balducci A; Casadio C; Farina P; Staffa M; Valenti L; Milani M Int J Dermatol; 2003 Jul; 42(7):572-5. PubMed ID: 12839615 [TBL] [Abstract][Full Text] [Related]
6. A randomized comparative study of the efficacy of topical latanoprost versus topical betamethasone diproprionate lotion in the treatment of localized alopecia areata. Bhat S; Handa S; De D Indian J Dermatol Venereol Leprol; 2021; 87(1):42-48. PubMed ID: 33580923 [TBL] [Abstract][Full Text] [Related]
7. Intralesional Triamcinolone Acetonide Versus Topical Betamethasone Valearate in the Management of Localized Alopecia Areata. Devi M; Rashid A; Ghafoor R J Coll Physicians Surg Pak; 2015 Dec; 25(12):860-2. PubMed ID: 26691357 [TBL] [Abstract][Full Text] [Related]
8. The Role of 5% Minoxidil versus Platelet-Rich Plasma in Treatment of Alopecia Areata. Ghafoor R; Saher N; Ali SM J Coll Physicians Surg Pak; 2024 Jun; 34(6):650-653. PubMed ID: 38840345 [TBL] [Abstract][Full Text] [Related]
9. Treatment of alopecia areata with nonablative fractional laser combined with topical minoxidil. Wang W; Gegentana ; Tonglaga ; Bagenna ; Li Y J Cosmet Dermatol; 2019 Aug; 18(4):1009-1013. PubMed ID: 31245963 [TBL] [Abstract][Full Text] [Related]
10. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. Olsen EA; Carson SC; Turney EA Arch Dermatol; 1992 Nov; 128(11):1467-73. PubMed ID: 1444500 [TBL] [Abstract][Full Text] [Related]
11. Randomized comparison of topical betamethasone valerate foam, intralesional triamcinolone acetonide and tacrolimus ointment in management of localized alopecia areata. Kuldeep C; Singhal H; Khare AK; Mittal A; Gupta LK; Garg A Int J Trichology; 2011 Jan; 3(1):20-4. PubMed ID: 21769231 [TBL] [Abstract][Full Text] [Related]
12. Topical minoxidil (3%) in extensive alopecia areata, including long-term efficacy. Price VH J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):737-44. PubMed ID: 3549810 [TBL] [Abstract][Full Text] [Related]
13. Childhood Alopecia Areata: An Overview of Treatment and Recent Patents. Hon KL; Luk DCK; Leung AKC; Ng C; Loo SKF Recent Pat Inflamm Allergy Drug Discov; 2020; 14(2):117-132. PubMed ID: 32723274 [TBL] [Abstract][Full Text] [Related]
14. Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata. Fiedler-Weiss VC J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):745-8. PubMed ID: 3549811 [TBL] [Abstract][Full Text] [Related]
15. Platelets rich plasma versus minoxidil 5% in treatment of alopecia areata: A trichoscopic evaluation. El Taieb MA; Ibrahim H; Nada EA; Seif Al-Din M Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27791311 [TBL] [Abstract][Full Text] [Related]
16. Extensive alopecia areata: not necessarily recalcitrant to therapy! Deshpande D; Dhurat R; Saraogi P; Mishra S; Nayak C Int J Trichology; 2011 Jul; 3(2):80-3. PubMed ID: 22223966 [TBL] [Abstract][Full Text] [Related]
17. Comparative study between topical methotrexate 1% gel and minoxidil 5% gel in the treatment of localized alopecia areata. Toma DM; Atallah RB; Eldahshan RM Dermatol Ther; 2022 Sep; 35(9):e15696. PubMed ID: 35796224 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and Influence Factors of 308-nm Excimer Lamp with Minoxidil in the Treatment of Alopecia Areata. Li A; Meng X; Xing X; Tan H; Liu J; Li C Lasers Surg Med; 2020 Oct; 52(8):761-767. PubMed ID: 31919885 [TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of the efficacy of topical tacrolimus 0.03% and topical calcipotriol 0.005% mixed with betamethasone dipropionate versus topical clobetasol 0.05% in treatment of alopecia areata: A clinical and trichoscopic study. Nassar A; Elradi M; Radwan M; Albalat W J Cosmet Dermatol; 2023 Apr; 22(4):1297-1303. PubMed ID: 36575890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]